NEW STEP BY STEP MAP FOR HOW EFFECTIVE IS PEMBROLIZUMAB

This prevents the activation on the T-cell which Generally would target and damage cancer. The cancer cells can then multiply and distribute. When Keytruda binds to your PD-1 receptor it stops cancer cells from linking to and inactivating T-cells, enabling T-cell re-activation, and boosting the immune system's response against cancer. This affects